R D Schouten
Overview
Explore the profile of R D Schouten including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
656
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schouten R, Schouten I, Schuurbiers M, van der Noort V, Damhuis R, van der Heijden E, et al.
PLoS One
. 2024 Jul;
19(7):e0290939.
PMID: 39083479
Introduction: Molecular profiling of NSCLC is essential for optimising treatment decisions, but often incomplete. We assessed the efficacy of protocolised molecular profiling in the current standard-of-care (SoC) in a prospective...
2.
de Vries R, Muller M, van der Noort V, Theelen W, Schouten R, Hummelink K, et al.
Ann Oncol
. 2019 Sep;
30(10):1660-1666.
PMID: 31529107
Background: Immune checkpoint inhibitors have improved survival outcome of advanced non-small-cell lung cancer (NSCLC). However, most patients do not benefit. Therefore, biomarkers are needed that accurately predict response. We hypothesized...
3.
Mazieres J, Drilon A, Lusque A, Mhanna L, Cortot A, Mezquita L, et al.
Ann Oncol
. 2019 May;
30(8):1321-1328.
PMID: 31125062
Background: Anti-PD1/PD-L1 directed immune checkpoint inhibitors (ICI) are widely used to treat patients with advanced non-small-cell lung cancer (NSCLC). The activity of ICI across NSCLC harboring oncogenic alterations is poorly...